Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah it has been tough to watch - EMHTF will do great!
Also keep in mind they own 65% of the Dealer's License obtained from Abattis (was just recently increased from 53% to 65%). The DL clearly differentiates them from other LPs
You better believe it
Second reading passes 44 to 29 - Conservatives learn that the Independents appointed by PM Trudeau actually support Trudeau - DUH! This is a done deal folks - From here on the Conservatives in the Senate will just be a loud critic - nothing more - The fight is over.
Lvannoy - You should join the Abattis Investors Club FB Page - Your contribution is appreciated by committed and Informed Longs.
So funny - Do you want to discuss? - Make you best non-convoluted point - just one - And do your best - Your very best to make it non-convoluted - Then we shall respond Jimdork?
Legalization in Canada will happen sooner than misunderstood by most...
https://www.facebook.com/photo.php?fbid=10211713143967479&set=p.10211713143967479&type=3&ifg=1
From our FB Page,
The PPs had 4 month holding periods - So from the October PP we would have approximately 45,000,000 shares that came available for trading around third week February - 1/2 @ .18 and the other 1/2 @ .25 - Once all that cheap paper is gone there is nothing left until we get to the Late December PP and that takes everything to a new level because that was about 14,000,000 shares priced @ .43 - Those shares are tradable around the end of April and the warrants were priced at .65 cents - So I have heard lots of grumbling about why so many shares can trade everyday without a corresponding increase in SP - I believe we are working our way through this - Keep in mind after this we are in pretty strong hands - 100,000,000 of our shares are now in the hands of a few business owners that believed they would be far better off joining the Abattis journey rather than join others or continue on their own.
The claim NC will harvest more Hemp in 2018 that was harvested in all of the US in 2017 - Aiming for 25,000 acres.
Yes - That is their symbol - OTC
Pun intended?
If investors here actually continue to think this is a pump LOL - I welcome educated discussion - Why would we not want to contribute to our common success?
It is a well known saying that free press is the best press.
Good the OTC does their DD - Nice to get the extra free press I guess? At least in our response we were able to sit there and say - Oh - maybe it is because of all these awesome news releases and Milestones We Have Achieved - And give all the dates of the milestones and news releases for a complete new set of potential investors to read and most likely invest.
I have been checking SEDAR - I still do not see it - Can you post the link here.
That was a great post - Thanks!
Do we think the THE GABRIOLA NR TODAY IS FORSHADOWING - Milestones being met are understood best by those who know - Does anyone here not think Gabriola is Abattis' poster child client? - Smaller (there will be Hundreds by 2020) Growers lacking the Expertise - Capital - Technology to Extract - Formulate - Infuse Health Canada (already approved) Natural Health products.
I am in Vancouver - Likely 2-3 month delay - No big deal - We need to get our ducks lined up anyway = A bit more time.
It is Q1 2018 we are waiting on - Due 60 days I believe - Year End is September 31st - Zero revenue - 1st Q due out any day but S/B by March 1st I believe.
Abattis has been tight-lipped regarding the GT Therapeudics acquisition - This has caused uneasiness amongst some of us because it was probably the biggest deal Abattis has ever done - for sure the largest I have ever seen (by $ value that is). With the GT Therapeudics' website down and practically zero information online etc... (I know I have searched hours looking for vape pens!) Eventually there are rumblings about GTT being nothing more than a shell company - This old Winston Resources News Release will provide insight on the level of DD Winston was completing on GTT - My DD has provided myself with more than enough confidence that GTT was a real company and that the acquisition our Team accomplished was admirable. Highlights from this OLD NR below,
"Mr. Jang brings more than 25 years of experience in the mining industry and has extensive knowledge of Sarbanes-Oxley, internal controls, mergers and acquisitions, tax planning, and regulatory compliance matters."
"Mr. Jang has worked with Lundin Mining Corp., Augusta Resources Corp., Hudbay Minerals Inc. and Pan American Silver Corp. in various roles ranging from corporate controller to vice-president. He is a graduate of the British Columbia Institute of Technology's financial management program and holds a CPA, CMA designation."
2017-03-07 10:20 ET - News Release
Mr. Shawn Bromley reports
WINSTON RESOURCES INC. APPOINTS GORDON JANG AS CHAIRMAN OF ADVISORY BOARD
Winston Resources Inc., in conjunction with its proposed acquisition of Green Tree Therapeutics, has appointed Gordon Jang as chairman of the company's advisory board. The advisory board will enhance the company's ability to bring in tactical growth partnerships through strategic investments, which are an important part of the company's approach to capture sales and the newest developing technologies in the cannabinoid sector.
Mr. Jang brings more than 25 years of experience in the mining industry and has extensive knowledge of Sarbanes-Oxley, internal controls, mergers and acquisitions, tax planning, and regulatory compliance matters.
Mr. Jang has worked with Lundin Mining Corp., Augusta Resources Corp., Hudbay Minerals Inc. and Pan American Silver Corp. in various roles ranging from corporate controller to vice-president. He is a graduate of the British Columbia Institute of Technology's financial management program and holds a CPA, CMA designation.
Mr. Jang brings invaluable experience, expertise and insight, and the company looks forward to developing numerous growth strategies. Mr. Jang will be granted options at a later date, subject to approval by the Canadian Securities Exchange.
Update on proposed transaction
On Feb. 24, 2017, Winston signed a letter of intent with GT Therapeutics Corp., doing business as Green Tree Therapeutics, an arm's-length private British Columbia company, pursuant to which the company will complete a reverse takeover and acquire from Green Tree Therapeutics' shareholders 100 per cent of the shares of Green Tree Therapeutics, causing Green Tree Therapeutics to become a wholly owned subsidiary of Winston. On completion of the transaction, the business of Green Tree Therapeutics will become the business of Winston, and the company will abandon the Pigeon River property.
The company continues to work through due diligence and negotiation of the definitive agreement. The transaction remains subject to certain closing conditions, including completion of due diligence, the negotiation and signing of a definitive agreement, and obtaining all necessary approvals, including approval of the respective boards, the approval of the Canadian Securities Exchange, and if applicable, shareholders of the company. There can be no guarantees that the transaction will be completed as proposed or at all.
I am also still here - Waiting for Financials and comprehensive update, i.e. Where is our capital going?
Abattis Hopes Consumers Will Say, "Mmmmm, Cannabis Beer"
By: Tomas Ronolski - AllPennyStocks.com News
Monday, January 22, 2018
Like so many real people in the world, Homer Simpson, everyone's favorite lovable beer-drinking cartoon dad, sure loves his beer. Abattis Bioceuticals (CSE:ATT)(OTCQB:ATTBF) thinks consumers are going to love beer infused with hemp, a variety a cannabis. Before you go thinking people are going to get stoned on beer like they do smoking marijuana, understand that the beer with have no THC (tetrahydrocannabinol) in it, the cannabis constituent responsible for the psychotropic effect. The plan is to infuse the beer with other "high-free" cannabinoids found in cannabis that are believed to have medical benefits.
To make it happen, Abattis, a Vancouver-based life sciences a biotech company specializing in cannabis technologies, has partnered with Faculty Brewing. The company says it is one of the first Canadian companies to secure an agreement to move forward with developing functional, cannabis- and hemp-infused beers, which it expects to have ready for markets once Health Canada releases its new guidelines on beverages involving cannabis.
Northern Vine Laboratories, a licensed cannabis dealer co-owned by Abattis and Emerald Health Therapeutics (TSX-V:EMH)(OTCQB:EMHTF), has been contracted to provide cannabinoid-rich, THC-free hemp extract for the requisite research to make the new brew.
Shares of CSE-listed ATT are up 3 cents, or 4.9%, to $0.64 in Monday trading following the news. U.S.-listed shares are doing slightly better, rising 6.3% to 51 cents as the trading days enters its last half-hour before the closing bell.
Company Highlight
Hemp-Infused, Cannabinoid-Rich, THC-Free Craft Beers Coming to a Store Near You
Posted: Jan 24, 2018 5:17 AM PST
Updated: Jan 24, 2018 5:17 AM PST
VANCOUVER, BC / ACCESSWIRE / January 24, 2018 / Beer drinkers and cannabis consumers can share in rejoicing the flood of options that will soon be available to them, with Canada’s upcoming marijuana legalization on the horizon. Through edits made to Bill C45, Canadian lawmakers quietly made an impactful change that will effect consumers’ choices in what they can eat and drink—opening the door to major opportunities for investors in the space.
In particular, there are several opportunities within what looks to be a cannabinoid-beverage crossover market, with companies including Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF), Canopy Growth (WEED) (TWMJF), Phivida Holdings Inc. (VIDA) (PHVAF) and The Tinley Beverage Company Inc. (QRSRF) (TNY).
By looking at the Colorado market, which is the longest running legalized state in North America, the potential for edibles and beverages is very high—and Colorado just approved cannabinoid-infused beers (no THC, but CBD).
The market is opening up at a fast pace. According to data from cannabis business data firm BDS Analytics, legal sales of marijuana edibles totaled $90.41 million US in 2014, $126.17 million US in 2015, and later ballooning to $189.9 million US in 2016.
Ahead of this rush, in October, the crossover beverage-cannabis market received its biggest news yet, when multi-billion-dollar cannabis player Canopy Growth (WEED) (TWMJF) sold a 9.9% equity stake to beverage giant Constellation Brands (STZ)—owners of the Corona brand of beers and many more.
As a result, the floodgates have been opened, as the prospect of a wide range of cannabinoid-infused beverages (including beer!) to be developed between now and official legalization in Canada, raised the potential of more major deals like that of Constellation and Canopy.
The latest was the announcement of Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF), of its newly-formed partnership with Faculty Brewing, to move forward in developing “high-free” cannabis- and hemp-infused beers, to hit the markets as soon as Health Canada releases its new guidelines regarding beverages involving cannabis.
CANNABINOID-INFUSED BEVERAGES SOON TO HIT SHELVES
When Corona’s owner Constellation Brands made an aggressive move to buy 9.9% of cannabis giant Canopy Growth, there was a buzz around both the beverage and cannabis sectors.
The deal, valued at $191 million (CAD$245 million), kicked off Canopy’s biggest rally to date—boosting the share price from $12.79 to a high of $20.38 for an increase of nearly 60%. The company is now trading over $40 per share, and the company has a higher market cap than Air Canada.
Given that the cannabis industry is expected to be worth $50 billion by 2026, the market will cater all types of forms for consumption.
Enter Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF), which has positioned itself to be a prominent leader in this crossover space.
Recently the company announced a strategic partnership with private liquor distribution alliance ABLE BC, putting Abattis in a solid position with points of sale for alcohol and eventually cannabis, across the province of BC.
This week, Abattis made even bigger waves, by announcing a new partnership with Faculty Brewing, to develop a line of cannabinoid-rich, hemp-infused, THC-free craft beers.
Now Abattis has not only a foothold in some of the most prominent points-of-sale for alcohol in its home province, but it also will have a highly marketable product to stock the shelves (and coolers) with.
ABATTIS BREWING WITH EXPERTISE AND ACCESS
The prospect of marketing a new line of cannabinoid-infused craft beers, amidst a market obviously thirsty for new options and awaiting Health Canada’s green light, hasn’t been lost on Abattis’s management.
“By aiming to develop a line of functional beers, each based on a different type of hemp extract, we hope to have a product that is compliant and market-ready as soon as Health Canada releases its new regulatory framework for hemp and cannabis-infused beverages,” said Rob Abenante, President and CEO of Abattis.
When it aligned with ABLE BC, Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) not only established themselves as technical experts during the commercial cannabis rollout, but also readied themselves for when their cannabinoid beer lines officially launch.
As part of the ABLE BC deal, Abattis assumed the role of providing technical expertise—especially when it comes to quality assurance for dosage, terpene analysis, potency, and more.
Key to both Abattis developments, are the company’s subsidiaries, including leading laboratory Northern Vine Labs—a shared subsidiary with Emerald Health Therapeutics, Inc. (EMH) (EMHTF) located in BC, that’s envied in the sector for its extraction, testing and analysis. Abattis partnered with Emerald Health on Northern Vines in order to perform cannabinoid testing, in return for access to the lab, and extraction of CBD for hemp oil products.
The lab has been contracted by Abattis to provide the cannabinoid-rich, THC-free, hemp extract for the line of beers, and to carry out further research, development and analytical testing.
“Having the [lab] on board ensures the final product will deliver a precise and consistent amount of pesticide-free cannabinoids in every single bottle,” said that lab’s Dr. David Galvez, who is also the Senior Science Advisor for Abattis.
Supplementing the potential for the newly-formed partnership between Abattis and Faculty Brewing, will be Abattis’s wholly-owned subsidiary Vergence Naturals.
Vergence is the fully-equipped marketing and distribution arm of the Abattis empire, which has been tasked from the beginning with handling all of the company’s cannabinoid-infused products.
Among those products, the company recently added the brand Green Tree Therapeutics to its portfolio.
Green Tree is primarily known for its brand of vape pens, which are already sold within several brick and mortar stores, and over 130 outlets in total.
While not a multi-billion-dollar company like Canopy Growth (WEED) (TWMJF), Abattis has strategically positioned itself as an expert in extraction and testing, as well as cannabinoid-infused product marketing.
For Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF), there is plenty of space to grow within the cannabis sector and has several options available for when legalization is finally official.
COMPARABLES
Canopy Growth Inc. (WEED) (TWMJF)
Owners of the Tweed brand of cannabis products, Canopy Growth is a multi-licensed, geographically diverse marijuana producer, described as “one of the world’s — and Canada’s first — premier exporters of marijuana” by the Financial Post in 2016. Canopy is the parent company of licensed cannabis producers, Tweed Inc., Tweed Farms Inc., Bedrocan Canada Inc., as well as newly acquired Mettrum Health Corp. Canopy currently has a combined growing platform of over 665,000 sq. ft. of production space. It was also the first federally regulated, publicly traded cannabis producer in North America, and the first billion-dollar cannabis corporation. Canopy Growth was founded in 2014, and is based in Smith Falls, Ontario.
Phivida Holdings Inc. (VIDA) (PHVAF)
Phivida engages in purchasing, packaging, and selling holistic hemp infused remedies. They provide hemp oil extracts to the manufacturers of consumer packaged goods, such as pet supplements, e-juices, topical ointments, cosmetics, and pharmaceuticals; vitamin juices, iced tea products, and nutritional protein shakes; and tinctures and vitamin shots under the Vida+ brand name. Phivida Holdings Inc. was incorporated in 2015 and is based in Vancouver, Canada.
The Tinley Beverage Company Inc. (QRSRF) (TNY)
The Tinley Beverage Company develops, manufactures, and distributes drinkable cannabinoid products in the United States. It offers a line of hemp cannabidiol (CBD) infused drinkable supplements. The Tinley Beverage Company Inc. is based in Toronto, Canada.
Read more at http://www.stockhouse.com/companies/bullboard#gpO709bJ9BEIHCrK.99
Share Price is down because we issued 100MM shares since Christmas break.
For something a bit more up to date - This is from the Canadian Facebook Page Group Post.
Lets agree to aggregate at a central focal point for our combined efforts in moving the virtues of the Company forward @ the Group's Facebook Page - Which grew by 25% Today.
Should not be considering the purchase of any LP
Just my opinion but from my DD it is my understanding that Abattis has secured its Biomass needs through the Partnership with Emerald - Of course the devil is always in the details but as far as the comments our President has made in the media... Well I think it is all there...
"Supply of raw cannabis product for research and product development is no longer an issue"
"I should mention as well that our extraction business, utilizing Raybot's proprietary, low cost and efficient technology, should see a significant boost"
"I would say that the timeline to achieve many of our goals has been shortened through the Emerald Health Partnership"
RA: Our general approach to the market really hasn't changed. I would say that the timeline to achieve many of our goals has been shortened through the Emerald Health partnership. With a premier partner like Emerald we have instantly raised our profile in the market. Better access to capital should help us speed things along tremendously. Supply of raw cannabis product for research and product development is no longer an issue. I should mention as well that our extraction business, utilizing Raybot's proprietary, low cost and efficient technology, should see a significant boost. So rather than a change in approach, we think we'll be able to ramp up all aspects of our business much more quickly than we could have prior to this partnership.
I believe that with a group like Emerald taking such a large stake in our lab, it serves to validate our ability to establish labs of the highest standards, a strategy we can now expand and grow across Canada in a rapid fashion. We will quickly look to roll out our X-Labs laboratory model across Canada and establish ourselves as the leading independent testing facility in Canada as more and more LP's come online.
IMO - The millions raised will be put forth to open multiple X-Lab locations simultaneously - Just My Opinion - GLTA.
Read more at http://www.stockhouse.com/companies/bullboard#UXWGWD7r3RsuHUsc.99
I think some of those investors may have already dipped their toe into Abattis - Afterall the NR stated the first two PPs were for loyal and strategic investors - Also - GTT apparently has top line revenue so that should translate nicely onto our books.
I agree completely with you regarding Dilution - I have been thinking same - I believe - Just MO that the reason they went to market and raised so much cash is because they realize they cannot open one X-Lab at a time and that they need to enter the space on a Grander Scale.
They cannot wait that long - First X-Lab needs to be announced by end of next week IMO - Things moving way to fast here in Canada.
It is in the business Plan that was published to the Co. website in September - The Plan is to open the first X-Lab in BC and then stamp out X-Labs in every major province - I believe Plans have recently changed - JMO - The fact that they have been raising so much capital lately - I believe they have Multiple LP alignment agreements about to be announced and that is why they require so much capital uo front - As I posted on another Board - Abattis wants to be Leaders in the Extraction space - And also Disrupt that space with Raybot Tech. Capabilities - I think they need to enter big - Thus forget the "stamp out X-labs" one by one - I am betting my Cash that they already have multiple agreements lined up with LPs some of whom may not even have a licence to sell - but are Industrial scale Cultivators - And that is what there has been a recent Dash to Raise Cash - How many X-Labs are we about to announce Folks? JMHO - GLTA :)
Here is the NR I was referring to,
Radient to produce pot extracts for Terra Life Sciences
2017-12-11 07:39 ET - News Release
Mr. Mike Cabigon reports
RADIENT TECHNOLOGIES INC. ANNOUNCES MASTER SERVICES AGREEMENT WITH TERRA LIFE SCIENCES
Radient Technologies Inc. has signed a master services agreement to produce cannabis extracts for the Terra Life Sciences group, a private, Alberta-based pharmaceutical manufacturer whose ACMPR (Access to Cannabis for Medical Purposes Regulations) licence is expected in the near future.
Under the terms of the agreement, Radient will use its proprietary microwave-based extraction platform and decades of extraction expertise to deliver extraction as a service to Terra Life Sciences. From its Edmonton facility, Radient will process and refine Terra Life Sciences' cultivated cannabis material into permitted cannabis oil products at industrial-scale throughput and high yields, while maintaining rigorous quality and product safety standards.
With its subsidiary Olds SoftGels Inc. (OSG) and OSG's production capacity of over 2.5 billion softgel capsules a year from two GMP-certified facilities, Terra Life Sciences is well positioned to develop innovative, pharma-grade cannabis and CBD-based products at scale, enabled by the economic and operational advantages provided by Radient's platform.
"We are excited to be a partner in Terra Life Sciences' product development and value chain as they address the rapidly growing medical applications of cannabis and CBD-based products," said Mike Cabigon, chief operating officer of Radient. "Furthermore, we anticipate a number of important synergies between the two companies as we address consumer needs."
Dr. Anil Jain, president and chief executive officer of Terra Life Sciences, added: "Through the use of MAP, Radient has a proven, high value extraction system that will help bring to market a number of exciting products. It is important for us to solidify this relationship because it will provide us access to large-scale extraction capacity for producing high-quality pharma-grade medicine."
About Radient Technologies Inc.
From their Corporate Presentation their plans are to open their first XLab in British Columbia, (I am thinking most expect to be aligned with Emerald - Then with all the cash they have they should be making deals with other LPs in Canada (these will likely not be the big mainstream guys) that have the license to grow and sell but lack the extraction expertise as well as the formulation experienceand know how - If you look at Radient's recent NRs there is one in there where they announced this exact type of deal - MINUS the Lab part as they do not have a Dealer's License like Abattis does - So I look at that NR and this is what I expect to see only more due to the fact that Abattis can also provide the Dealer's License Lab expertise and with all the other business lines they have I also expect many other types of NRs as well.
I have called and LMTC me back as well as emailed them, (incl. Rob) as it seems like a no-brainer to me - Let me know if you get through and I will do same.
And Europe as well - Remember they have exclusive rights to Raybot's technology for North America and Europe - And as a Licensed Dealer can export their finished goods to those markets as well.
MONTREAL – Prime Minister Justin Trudeau says “next summer,” and not July 1, is the date cannabis will become legal across the country.
Excerpts of an interview Trudeau gave the TVA network in Quebec were broadcast Tuesday, with the full interview to be shown Wednesday night.
READ MORE: Canadians could pay at least $1 per gram in weed tax, plus GST: feds
Trudeau shook his head when interviewer Pierre Bruneau asked him why he was so obsessed with July 1 as the date for the cannabis legislation to become law.
The prime minister said it “would not be July 1,” but that it would be “for next summer.”
“The date will not be July 1, I can assure you of that,” Trudeau said. “I don’t know where that date came from.”
WATCH: Stats Canada crowdsourcing info on pot prices
Be informed all as it is a very important point - Legal Rec Pot in Canada is Not set for July 1st - It is st to be Legal by July1st - Count on an earlier date my friends
That was why I finally went big - If you believe what Abattis claims Raybot can achieve then you should be all over this opportunity - When Emerald partnered with them that was all I needed - GLTA
Looks like the investment community is beginning to realize...
Not sure what you are saying - Really appreciate your comments - I am awful at subtleties - Thanks for clarification in advance.
How much money did EMH make in the last Q? Top line was what a couple hundred grand? Bottom line deficit right - So what - All the capital in the US is heading north and the CSE is becomming a major recipient - Try investing in a POT company as a US investor - Abattis IMO has the distribution channels in place and the goods to make a run at a burgeoning industry - I agree place your bets - GLTA - Go Long Abattis!